跳至主要内容
临床试验/ACTRN12621000785808
ACTRN12621000785808招募中1 期

A Phase 1 Study to Evaluate the Effect of Itraconazole on thePharmacokinetics of GS-5718 and to Evaluate the Effect ofGS-5718 on the Pharmacokinetics of Rosuvastatin in HealthySubjects

Gilead Sciences0 个研究点目标入组 32 人开始时间: 2021年6月22日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
All

入选标准

  • Have the ability to understand and sign a written informed consent form (ICF), which must
  • be obtained prior to initiation of study procedures
  • - Be a nonsmoker. The use of nicotine or nicotine-containing products must be discontinued
  • 90 days prior to the first dose of study drug.
  • - Have a calculated body mass index (BMI) of > 19.0 and < 30.0 kg/m2 at screening

排除标准

  • - Positive serum pregnancy test
  • - Breastfeeding female
  • - Male subjects who plan to donate sperm from clinic admission (eg, Day -1), throughout the
  • study period, and/or within 14 days following the last dose of study drug
  • - Have received any investigational study drug within 30 days prior to study dosing
  • - Have current alcohol or substance abuse judged by the investigator to potentially interfere with subject compliance or subject safety, or a positive drug or alcohol test at screening or baseline

研究者

相似试验